findmyKOL
Clinical trialNCT00690092CompletedPhase 3Interventional

A Multi-center Study of Spherule-Derived Coccidioidin

SponsorNielsen BioSciences, Inc.Enrollment113Coccidioidomycosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Health Sciences Center Avahcs, Univ. of Arizona

    Tucson, Arizona, United States

  • Kern Facility Medical Group

    Bakersfield, California, United States

  • Blair Clinic

    Blair, Nebraska, United States

  • Spokane Allergy and Asthma Center

    Spokane, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2005
Primary completion
30 Sept 2007
Completion
30 Sept 2007
Last update posted
29 Oct 2013
Registered enrollment
113
Registry id
NCT00690092

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.